Cancer Center Clínica Universidad de Navarra (CCUN)

2018

1. Aligning digital CD8 + scoring and targeted next-generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early-stage squamous cell lung carcinoma

   Histopathology, Vol. 72, Núm. 2, pp. 270-284

2. Assessment of metabolic patterns and new antitumoral treatment in osteosarcoma xenograft models by [ 18 F]FDG and sodium [ 18 F]fluoride PET

   BMC Cancer, Vol. 18, Núm. 1

3. TPEN exerts antitumor efficacy in murine mammary adenocarcinoma through an H 2 O 2 signaling mechanism dependent on caspase-3

   Anti-Cancer Agents in Medicinal Chemistry, Vol. 18, Núm. 11, pp. 1617-1628

4. A 30-s exposure to ethanol 20% is cytotoxic to human keratinocytes: possible mechanistic link between alcohol-containing mouthwashes and oral cancer

   Clinical Oral Investigations, Vol. 22, Núm. 8, pp. 2943-2946

5. A 60-Year-Old Male Smoker With Chronic Obstructive Pulmonary Disease and Hypereosinophilia

   Archivos de Bronconeumologia, Vol. 54, Núm. 7, pp. 394-395

6. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers

   Brain, Vol. 141, Núm. 10, pp. 2895-2907

7. A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer

   Clinical Breast Cancer, Vol. 18, Núm. 4, pp. e613-e619

8. A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization

   Cell, Vol. 175, Núm. 2, pp. 313-326

9. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation

   EMBO Molecular Medicine, Vol. 10, Núm. 12

10. A Technology-Enabled Solution to Manage Referrals to Hospice and Palliative Care Beds: The Ottawa SMART System as a Case Study

    Healthcare quarterly (Toronto, Ont.), Vol. 20, Núm. 4, pp. 63-67

11. A diphenyldiselenide derivative induces autophagy via JNK in HTB-54 lung cancer cells

    Journal of Cellular and Molecular Medicine, Vol. 22, Núm. 1, pp. 289-301

12. A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

    Nature Communications, Vol. 9, Núm. 1

13. A lncRNA GUARDINg genome integrity

    Nature Cell Biology, Vol. 20, Núm. 4, pp. 371-372

14. A multicentre, randomized controlled trial of telehealth for the management of COPD

    Respiratory Medicine, Vol. 144, pp. 74-81

15. A new model of exercise referral scheme in primary care: Is the effect on adherence to physical activity sustainable in the long term? A 15-month randomised controlled trial

    BMJ Open, Vol. 8, Núm. 3

16. A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients

    Journal of Pathology, Vol. 245, Núm. 4, pp. 421-432

17. A phase I/II dose-escalation study investigating all-oral ixazomib-melphalanprednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma

    Haematologica, Vol. 103, Núm. 9, pp. 1518-1526

18. A phase ii multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy

    Haematologica, Vol. 103, Núm. 8, pp. 1351-1358

19. A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma

    Oncogene, Vol. 37, Núm. 27, pp. 3740-3752

20. A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis

    Journal for ImmunoTherapy of Cancer, Vol. 6, Núm. 1